Nature Search

Response to the letter from Drs Brock and Bellman

Roderick Skinner
Correspondence01 Jan 1991
British Journal of Cancer

Volume: 63, P: 160
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) is an anti-inflammatory drug proposed as a treatment for COVID19. Here the results are reported from a randomised trial testing DMF treatment in 713 patients hospitalised with COVID-19. DMF was not associated with any improvement in day 5 outcomes.

Peter Sandercock
Janet Darbyshire
Martin J. Landray
ResearchOpen Access31 Jan 2024
Nature Communications

Volume: 15, P: 1-13
High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group

Adam Gassas
Ponni Sivaprakasam
Persis Amrolia
Research15 Mar 2018
Bone Marrow Transplantation

Volume: 53, P: 1165-1169
Single-molecule transport across an individual biomimetic nuclear pore complex

Covalently attaching nuclear pore proteins to solid-state nanopores forms a complex that can selectively transport certain proteins, similar to the nuclear pore complex.

Stefan W. Kowalczyk
Larisa Kapinos
Cees Dekker
Research19 Jun 2011
Nature Nanotechnology

Volume: 6, P: 433-438
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

This report identifies Cdk1's phosphorylation of BRCA1 as an important regulator of BRCA1's DNA repair function. Cdk1 inhibition renders cancer cells sensitive to PARP inhibition, and the combination treatment can inhibit tumor growth in vivo, expanding the potential application of PARP inhibitors beyond BRCA1-deficient tumors.

Neil Johnson
Yu-Chen Li
Geoffrey I Shapiro
Research26 Jun 2011
Nature Medicine

Volume: 17, P: 875-882
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Emma J. Heymer
Michael M. Hawkins
Raoul C. Reulen
ResearchOpen Access19 Jan 2024
British Journal of Cancer

Volume: 130, P: 976-986
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Ceren Sunguc
Michael M. Hawkins
Raoul C. Reulen
ResearchOpen Access01 Nov 2022
British Journal of Cancer

Volume: 128, P: 80-90
Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors

Natassia Robinson
John Casement
Gordon Strathdee
ResearchOpen Access30 Mar 2022
British Journal of Cancer

Volume: 127, P: 288-300

Search

Filter By:

Search

Quick links